The cost-effectiveness of prenatal screening for spinal muscular atrophy.

Little SE, Janakiraman V, Kaimal A, Musci T, Ecker J, Caughey AB. The cost-effectiveness of prenatal screening for spinal muscular atrophy. Am J Obstet Gynecol. 2010 Mar; 202(3):253.e1-7.

View in: PubMed

subject areas

Cost-Benefit Analysis
Cost-Benefit Analysis
Decision Support Techniques
Decision Support Techniques
Female
Female
Genetic Carrier Screening
Genetic Carrier Screening
Genetic Testing
Genetic Testing
Humans
Humans
Pregnancy
Pregnancy
Prenatal Diagnosis
Prenatal Diagnosis
Quality-Adjusted Life Years
Quality-Adjusted Life Years
Spinal Muscular Atrophies of Childhood
Spinal Muscular Atrophies of Childhood
Survival of Motor Neuron 1 Protein
Survival of Motor Neuron 1 Protein

authors with profiles

Sarah E Little